Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesPre-MDCDRG 010-pancreas-transplant
    Ask Trek AI about this page

    Pancreas Transplant: Inpatient Reimbursement Overview

    DRG 010 encompasses inpatient admissions for pancreas transplant procedures and associated perioperative care, important because it represents high-cost, resource-intensive surgical and medical management. Correct classification under this Diagnosis-Related Group affects Medicare inpatient reimbursement due to the complexity of care and potential presence of Major Complication or Comorbidity or Complication or Comorbidity that alter payment weights.

    Customize your policy alerts

    Sign up for drg 010 policy alerts

    Get alerted when payer policies referencing 010 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 010 Overview

    DRG 010 covers pancreas transplant procedures, including isolated pancreas transplants and combined pancreas-kidney transplants when coded to the principal procedure. This Diagnosis-Related Group captures high-resource surgical care with significant perioperative management, immunosuppression needs, and potential for major complications or comorbidities that affect length of stay and cost. It matters for Medicare payment because payment is adjusted to reflect the intensity of surgical, medical, and postoperative services required for transplant recipients. Accurate coding and documentation of procedures and complications influence classification and reimbursement under the Medicare inpatient prospective payment system.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Studies evaluating perioperative immunosuppression regimens and infection prophylaxis: randomized or observational studies that compare induction and maintenance immunosuppressive strategies (timing, dosing, and combination therapies) in adult pancreas transplant recipients, often including simultaneous pancreas–kidney (SPK) and pancreas-alone patients. These trials enroll patients during the transplant hospitalization and early post-operative period to measure acute rejection rates, infectious complications, graft survival at defined short-term intervals, and resource utilization. Findings are highly relevant to inpatient providers and payers because perioperative medication protocols and infection events drive length of stay, intensive care needs, readmissions, and immediate transplant success, all of which impact reimbursement and DRG-level costs.
    • Comparative effectiveness research on surgical technique and intraoperative management: multicenter cohort studies or pragmatic trials comparing different surgical approaches (eg, enteric vs bladder drainage of exocrine secretions, pancreas implantation sites, or minimally invasive vs open approaches) and intraoperative transfusion/anticoagulation strategies in heterogeneous transplant populations (SPK, pancreas after kidney, pancreas-alone). These studies focus on intraoperative complications, early graft thrombosis, bleeding, need for reoperation, and short-term functional outcomes within the initial hospitalization and 30–90 day window. Results inform surgeons, hospital administrators, and payers about which techniques reduce perioperative morbidity, use of costly resources (OR time, blood products, ICU), and early failure rates that significantly affect inpatient reimbursement and DRG case-mix decisions.
    • Longitudinal outcomes and health economics studies of post-discharge graft function and readmission drivers: prospective registries and cohort studies that follow pancreas transplant recipients after hospital discharge to evaluate long-term insulin independence, chronic rejection trajectories, quality of life, and patterns/costs of readmission related to metabolic complications, recurrent infections, or immunosuppression toxicity. These studies commonly stratify by pretransplant factors (age, comorbid kidney disease, diabetes duration) and perioperative events to identify predictors of costly downstream utilization and graft loss. Payers and health systems use this evidence to anticipate long-term cost implications of pancreas transplantation, design bundled payment or care pathways, and target interventions to reduce avoidable readmissions and maximize durable transplant benefit.

    Related Codes

    001-HEART-TRANSPLANT-OR-IMPLANT-OF-HEART-ASSIST-SYSTEM-WITH-MCC

    Heart Transplant or Implant of Heart Assist System with MCC: Inpatient Reimbursement Overview

    002-HEART-TRANSPLANT-OR-IMPLANT-OF-HEART-ASSIST-SYSTEM-WITHOUT-MCC

    Heart Transplant or Implant of Heart Assist System without MCC: Inpatient Reimbursement Overview

    003-ECMO-OR-TRACHEOSTOMY-WITH-MV-96-HOURS-OR-PRINCIPAL-DIAGNOSIS-EXCEPT-FACE-MOUTH-AND-NECK-WITH-MAJOR-O-R-PROCEDURES

    ECMO or Tracheostomy with MV >96 Hours: Inpatient Reimbursement Overview

    004-TRACHEOSTOMY-WITH-MV-96-HOURS-OR-PRINCIPAL-DIAGNOSIS-EXCEPT-FACE-MOUTH-AND-NECK-WITHOUT-MAJOR-O-R-PROCEDURES

    Tracheostomy with Mechanical Ventilation >96 Hours: Inpatient Reimbursement Overview

    005-LIVER-TRANSPLANT-WITH-MCC-OR-INTESTINAL-TRANSPLANT

    Liver Transplant with MCC or Intestinal Transplant: Inpatient Reimbursement Overview

    006-LIVER-TRANSPLANT-WITHOUT-MCC

    Liver Transplant without Major Complication or Comorbidity: Inpatient Reimbursement Overview

    007-LUNG-TRANSPLANT

    Lung Transplant: Inpatient Reimbursement Overview

    008-SIMULTANEOUS-PANCREAS-AND-KIDNEY-TRANSPLANT

    Simultaneous Pancreas and Kidney Transplant: Inpatient Reimbursement Overview

    011-TRACHEOSTOMY-FOR-FACE-MOUTH-AND-NECK-DIAGNOSES-OR-LARYNGECTOMY-WITH-MCC

    Tracheostomy/Laryngectomy with MCC: Inpatient Reimbursement Overview

    012-TRACHEOSTOMY-FOR-FACE-MOUTH-AND-NECK-DIAGNOSES-OR-LARYNGECTOMY-WITH-CC

    Tracheostomy and Laryngectomy with CC: Inpatient Reimbursement Overview

    Showing 1–10 of 16

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.